GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a substantial innovation in how we approach high blood sugar. These injectable therapies function to stimulating the body’s https://bookmarksfocus.com/story7492960/glp-1-a-major-advance-in-diabetes-care